Inhibition of C1q, C3, and CR3 can save synaptic loss and cognitive dysfunction in AD model mice, further supporting complement mediated microglial phagocytosis involved in AD synaptic loss (Tang et al., 2019). This evidence concerns the gene C3 and Alzheimer disease.